Second Cancers After Myeloma: Who Faces Higher Risk? | IMS 2026
Description
Talha Shaukat, a medical student collaborating with Cleveland Clinic, discusses racial and socioeconomic factors in second cancers after myeloma at IMS 2026 in Glasgow. A national registry study of about 7,000 myeloma patients who developed a second cancer used machine learning to look for patterns. Black patients developed second cancers sooner, including prostate cancer about three years earlier, and lower household income was also linked to higher risk. The findings suggest screening should be tailored to each person's risk.
If this video has helped you or a loved one, consider donating to HealthTree. Every donation helps us continue to create free and high-quality blood cancer educational content: https://give.healthtree.org/give/628617/src=htu
For an organized lesson structure, watch on our site here: https://linktr.ee/HealthTreeUniversity
Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer!
Patients have the key to find cures for cancer. Learn more about HealthTree's services here: https://healthtree.org/curehub?utm_source=social+media&utm_medium=htu+youtube&utm_campaign=htu-curehub&utm_content=general
Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.
Timestamps:
0:00 Introduction: Talha Shaukat, Research Collaborator, Cleveland Clinic
0:09 The Question: Second Cancers in Longer-Living Myeloma Patients
0:21 Registry Study of 7,000 Patients
0:37 Racial Differences in Second Cancers
0:51 Household Income and Second Cancer Risk
1:15 Machine Learning to Predict Risk
1:44 Why Screening Should Be Tailored to the Individual